The colorectal cancer molecular diagnostics market is projected to grow from USD 3.0 billion in 2025 to USD 6.4 billion by 2035, at a CAGR of 8.0%. Colorectal Cancer Molecular Diagnostic Reagents & Kits will dominate with a 53.7% market share, while pcr will lead the technology segment with a 47.5% share.